Edwards Lifesciences Corp
NYSE:EW
Net Margin
Edwards Lifesciences Corp
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | US |
| Market Cap | 51.1B USD |
| Net Margin |
23%
|
| Country | US |
| Market Cap | 182B USD |
| Net Margin |
14%
|
| Country | US |
| Market Cap | 135.1B USD |
| Net Margin |
27%
|
| Country | US |
| Market Cap | 123.6B USD |
| Net Margin |
16%
|
| Country | IE |
| Market Cap | 111.3B USD |
| Net Margin |
13%
|
| Country | US |
| Market Cap | 107.1B USD |
| Net Margin |
12%
|
| Country | US |
| Market Cap | 68.4B USD |
| Net Margin |
6%
|
| Country | DE |
| Market Cap | 58.9B EUR |
| Net Margin |
7%
|
| Country | CN |
| Market Cap | 371.2B CNY |
| Net Margin |
34%
|
| Country | US |
| Market Cap | 49.5B USD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 41.7B USD |
| Net Margin |
23%
|
Profitability Report
View the profitability report to see the full profitability analysis for Edwards Lifesciences Corp.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Edwards Lifesciences Corp's most recent financial statements, the company has Net Margin of 23%.
You don't have any saved screeners yet
